Rating: Cautiously Bullish | Target Price: HKD 30–37 | Current Price: HKD 22.8 (2026-10-27 close) | Margin of Safety: +32% | Time Horizon: 12 months
The target price of HKD 30–37 is the base-case fair value range, representing +31.6% to +62.3% versus the current price; the bear case is HKD 18–21.5 (-5.7% to -21.1%), and the bull case is HKD 47–60 (+106% to +163%).
Financial statements are reported in RMB, while share price and market cap are quoted in HKD; the exchange rate used throughout is 1 RMB = 1.1766 HKD (market rate as of 2026-10-28). Total share capital is 85,000,000 shares (including 1,352,300 treasury shares); at the 2026-10-27 closing price, total market cap is HKD 1.938 billion (approximately RMB 1.647 billion).
Bama Tea is China's No. 1 premium loose-leaf tea retail brand (~1.7% share of the premium tea market in 2024), listed on the HKEX on 2025-10-28 at an IPO price of HKD 50. One year after listing, the share price has retraced roughly 76% from the first-day close of HKD 93.35. Our view: this is a conditional opportunity driven by "deep value + a share supply event." The company holds net cash of approximately RMB 1.046 billion (63.5% of market cap), trades at EV of only ~2.0x TTM net profit attributable to shareholders, at 0.87x PB (below book) with a TTM ROE of 15.8%, and at a P/E (TTM) of ~5.5x; moreover, fundamentals showed a genuine inflection in 1H2026 (revenue +31.8%, net profit +65.4%, first interim dividend at a 51.5% payout ratio, plus a buyback launch). However, on 2026-10-28 (the 12-month listing anniversary), when 39.43% of share capital unlocked, the stock fell more than 25% intraday; a second wave of 37.57% unlocks on 2027-07-08, and the 10-day average daily turnover is only about HKD 0.93 million—supply and absorption capacity are severely imbalanced, and valuation convergence can only rely on dividend/buyback delivery and natural digestion of the share float. Core constraint: 1H2026's high growth relies on franchisee purchases and B2B custom orders, with end-market sell-through invisible; under a governance structure where the founding family holds ~50% of shares, whether the "supportive" dividend can become a normalized policy must be validated by the final dividend resolution in the 2027 annual results (March 2027). The current price already embeds pessimistic pricing of "zero profit growth + net cash never returned to shareholders." The odds are positive, but the path to realization is narrow and liquidity is extremely poor—suitable only for small positions and patient capital with a 12-month-plus horizon.
The primary share price driver over the next 12 months is not the earnings themselves, but the race between "cash delivery" and "share supply." On one hand, the unlock and the second unlock wave (combined, roughly 77% of share capital becoming tradable within the next 12 months) create a persistent overhang; on the other hand, the company paid its first interim dividend in 2026 (RMB 1.20/share, 51.5% payout ratio, payable by 2026-11-04) and has conducted buybacks for four consecutive months (July–September: ~HKD 40.87 million spent, with ~HKD 229 million remaining of the HKD 250 million mandate). If the 2027 annual results (March 2027) declare a final dividend bringing the full-year payout ratio to 50%, the implied dividend yield would be ~10%, elevating the channel for returning net cash to shareholders from a "one-off support measure" to a trackable policy.
A veritable expectation gap: Back-solving from the current price shows the market is pricing in "1H2026's high growth as a one-off inventory-loading pulse, normalized earnings flat-to-declining, and net cash never returned to shareholders" (EV ≈ 2.0x TTM attributable net profit; the only named sell-side firm, Huaxi Securities, has an FY2026E revenue forecast implying only +4.5% growth for 2H2026, with no target price anchor). If 2H2026 revenue growth holds at +10% to +20% (our base-case assumption) and the final dividend is paid, this pricing must be revised upward; if 2H revenue turns negative, the implied expectation becomes self-fulfilling.
Validation and falsification: Positive validation points = 2027 annual results (March 2027: revenue ≥ RMB 2.65 billion, attributable net profit ≥ RMB 320 million, final dividend ≥ RMB 0.4/share); no discount block-sale signals disclosed via HKEX post-unlock; buyback amounts scaling up to the tens-of-millions HKD level. Negative falsification points = 2H revenue turning negative year-on-year (full-year < RMB 2.42 billion); zero final dividend; large impairments of inventory aged over 36 months (RMB 120 million at end-2025); discounted placements by controlling shareholders or PE investors.
At the 2026-10-27 closing price, the implied value of the operating business after stripping out net cash is only ~RMB 600 million; back-solving with a cost of equity of 13%–16%, the current price implies a perpetual growth range of roughly -4% to +4% (midpoint ~-1%)—i.e., the market treats 1H2026's realized revenue +31.8% and net profit +65.4% as unsustainable pulses. For comparison: Bama's profit is ~2.6x that of Tenfu Tea, and its TTM ROE is more than double, yet its market cap is only 68% of Tenfu's, with a P/E of 5.5x vs Tenfu's 23.4x—this gap within the same sector and same market is a living specimen of liquidity and governance discounts. It must be emphasized: "cheap" is a verifiable fact; "cheap will converge" is not. The only convergence mechanisms are dividends, buybacks, and float digestion (see C3/C4)—which is why this report's stance stops at "cautious."
Three pillars of the 1H2026 inflection: ① Revenue mix—oolong tea +52.3%, online +36.1%, instant retail GMV +156%; ② Profitability—selling expense ratio down from 31.2% to 28.4%, listing expenses zeroed, net margin up to 14.1%; ③ Cash—operating cash flow of RMB 313 million. But three caveats must be applied simultaneously: first, OCF includes a one-off RMB 66.4 million collection of receivables from a terminated joint development project; excluding it, the cash-to-net-profit ratio is ~1.25 (still healthy, but not 1.58); second, advertising and promotion spend rose +39.5% (RMB 138 million → 193 million), faster than revenue—part of the growth was bought; third, contract liabilities of RMB 54.9 million were flat sequentially, a leading indicator that does not corroborate +31.8% revenue growth, and the company recognizes revenue at the franchisee payment stage with channel inventory invisible—the recovery in wholesale revenue per store (revenue +31.8% vs stores +7.3%) and a recovery in end-market sell-through are two separate propositions. The recent history of stagnation—near-flat revenue in 2024–2025 and consecutive declines in per-store revenue—still looms; 1H2026 is only a six-month sample. The channel-level disclosure in the March 2027 annual results is the sole adjudication point.
The unlock notional of 39.43% (~HKD 764 million at the 2026-10-27 close) versus a 10-day average daily turnover of HKD 0.93 million represents an order-of-magnitude gap. Structurally, however, intuition needs correction: shares held by the controlling family (acting-in-concert, ~50%) and by directors/supervisors remain subject post-unlock to statutory limits of no more than 25% transfer per year plus control-maintenance constraints. The true marginal selling pressure comes from pre-IPO financial investors: IDG (6.14%), Tiffany Arto (4.24%), and Nanhai Growth (3.71%), totaling 14.09% (~HKD 273 million)—at current turnover, that would take ~293 trading days to digest; measured against the full unlock notional, as long as ~822 trading days. Both figures point to the same conclusion: the unlock is not a "one-off clearing of negatives" but a supply-digestion period measured in quarters, with a second wave of 31,933,125 full-circulation conversion shares (37.57%) due on 2027-07-08. The company's buyback (October daily average of only HKD 200k–550k) annualizes to only ~2.4% of the unlocked overhang—a drop in the bucket. Liquidity cuts both ways: this stock was bid up to HKD 93.35 on its first trading day and hit a 52-week high of HKD 96.15, both also a function of an extremely small float—price discovery fails on this stock, so the valuation anchor must be dividend yield and asset value, not market sentiment.
The full dividend history is: FY2023 RMB 0.42/share (~15.5% payout) → FY2024 RMB 0.48/share (~16.1%) → FY2025 zero dividend (annual report citing "subsequent market capitalization management work") → 1H2026 interim RMB 1.20 (51.5%). The 51.5% ratio is more than three times the historical extreme, and payment timing came one week before the unlock date (10-28)—with existing evidence, a support motive and a policy shift are indistinguishable. Likewise, with the family concert party holding ~50%, roughly half of the RMB 102 million interim dividend flows to the family; the dividend carries dual attributes of minority-shareholder return and controlling-shareholder monetization. The conclusion is not to dismiss the dividend, but to attach a conditional label to the "~10% dividend yield" scenario: only if the March 2027 annual results declare a final dividend ≥ RMB 0.4/share (implying a full-year payout ratio of ~50%) and establish a written dividend policy will the 63.5% net-cash discount gain an institutional convergence mechanism; until then, the interim dividend should be treated as a one-off event.
Three facts about the industry landscape: ① Extreme fragmentation—the Chinese tea market (~RMB 325.8 billion in 2024) has a CR5 of only ~2.4%, and the premium segment's CR5 of ~5.6% has barely changed in five years; even the "No. 1 brand" holds only 1.7% absolute share (corresponding to premium revenue of ~RMB 1.75 billion, ~80% of the company's 2024 total revenue); ② Leaders are consolidating share—Bama's 3,845 stores are the most among Chinese tea companies, growing against the industry's store-closure wave; ③ But the ceiling is low—the industry's 2024–2029 CAGR is projected at only 4.6% (premium: 5.6%), and premium gifting demand is suppressed by regulation targeting holiday gift-giving and consumption downgrading (in Mid-Autumn 2026, value gift boxes at RMB 68–200 accounted for over 60%, with self-use exceeding gifting for the first time; peer Tenfu's 1H2026 revenue fell -7.2%). Bama's growth is essentially share redistribution rather than industry expansion. Two caveats on data: market share figures come from a paid report commissioned from Frost & Sullivan (the prospectus itself disclaims reliability), for reference only; franchisee count fell from 1,250 to 1,213 while store count rose—"counter-trend store expansion" is a combination of franchisee behavior and contraction in direct stores (316 → 226), not the same metric as the company's own share gains.
| Metric (RMB) | FY2023 | FY2024 | FY2025 | 1H2026 (latest) |
|---|---|---|---|---|
| Revenue (RMB 100M) | 21.22 | 21.43 | 21.96 | 14.02 (+31.8% YoY) |
| Net profit attributable to owners (RMB 100M) | 2.06 | 2.24 | 2.22 | 1.98 (+65.4% YoY) |
| Adjusted net profit (RMB 100M) | — | 2.35 | 2.41 | 1.98 (no adjustments this period) |
| Gross margin | 52.3% | 55.0% | 55.6% | 54.6% (-0.7pp YoY) |
| Net margin | 9.7% | 10.5% | 10.1% | 14.1% |
| Operating cash flow (RMB 100M) | 4.65 | 2.69 | 3.15 | 3.13 (incl. one-off collection of 0.66) |
| Free cash flow (RMB 100M) | 2.53 | 1.67 | 2.50 | 2.73 |
| Cash + cash-like assets (RMB 100M) | — | 3.47* | 9.79 | 12.19 (as of 2026-06-30) |
| Interest-bearing debt (RMB 100M, lease liabilities only) | — | 1.83 | 1.69 | 1.74 (no bank borrowings) |
| Debt-to-asset ratio | — | — | 31.9% | 28.6% |
| Contract liabilities (RMB 100M) | — | 0.53 | 0.55 | 0.55 |
| Total stores | — | 3,504 | 3,773 | 3,845 (226 direct / 3,619 franchise) |
| DPS (RMB) | 0.42 | 0.48 | 0 | Interim 1.20 (payable by 11-04) |
*FY2024 is cash and equivalents only; FY2025/1H2026 include time deposits over three months and structured deposits (restricted deposits of RMB 11 million counted separately, not included). The company is in a net cash position (net cash ~RMB 1.046 billion in 1H2026); net debt/EBITDA is not applicable. The adjusted metric is the company's disclosed non-IFRS measure (profit for the year + listing expenses - tax effects; FY2025 excludes RMB 25.3 million of listing expenses; the company has no equity incentives and no SBC add-back—a conservative treatment).
Reasons for metric changes (items ≥±20% YoY): ① 1H2026 revenue +31.8%—the company attributes it to "growth in franchisee purchases and contributions from customized procurement by major customers"; online +36.1%; ② attributable net profit +65.4%—operating leverage (selling expense ratio 31.2% → 28.4%) plus zeroed listing expenses (RMB 5.17 million in 1H2025); ③ advertising and promotion spend +39.5% (RMB 138M → 193M)—"actively advancing brand reputation building to enhance brand exposure"; ④ FY2025 inventory +31.9% while revenue grew only +2.5%—"the later 2026 Chinese New Year… increased finished-goods stocking in Q4 2025," with balances aged >36 months rising from RMB 80 million to 120 million (+50%), which management attributes to Pu'er tea's "aging process to enhance value"; ⑤ FY2025 trade payables +75.9%—"expanded business scale and increased procurement from suppliers"; ⑥ 1H2026 trade and other receivables -39.0%—full collection in February 2026 of RMB 66.4 million owed by a local institution (refund from a terminated joint development project).
1H2026 revenue was RMB 1.402 billion (+31.8%), attributable net profit RMB 198 million (+65.4%), gross margin 54.6% (-0.7pp, due to higher transport and warehousing costs), and net margin 14.1%, a post-listing high. Three structural highlights: oolong tea +52.3% (rock tea volume ramp), online share rising to 36.5% (revenue RMB 512 million, +36.1%, with instant retail GMV +156%), and in-house production share rising to 60.8% (self-produced revenue +43.0%, supported by capacity release from smart factories in Anxi/Wuyishan, underpinning gross margin). Three doubts to retain: ① Offline growth stems from franchisee payments and major-customer custom orders—wholesale per store and end-market sell-through are two different things; ② advertising spend +39.5% was front-loaded; if H2 spend recedes, revenue momentum and expense absorption may weaken simultaneously; ③ of the RMB 313 million OCF, RMB 66 million was a one-off refund; excluding it, the cash-to-net-profit ratio is ~1.25. On the market side: after the interim results, the stock rallied to HKD 33–34 from late August into early September (up over 50% in a month), then pulled back as the unlock approached; the only named sell-side coverage is Huaxi Securities (Buy maintained, FY2026E revenue RMB 2.586 billion), with no target price anchor—"whether results beat expectations" lacks a market consensus benchmark, so the only comparison is the company's own history: the 1H revenue growth rate is the highest half-yearly figure since 2023.
Intraday note (2026-10-28): This report's valuation basis is the 2026-10-27 closing price of HKD 22.8. Today (the day the 12-month post-listing lock-up expired), the stock fell more than 25% intraday to HKD 18.06, trading around HKD 18.5 (-19% vs prior close); verification confirms the driver was the unlock of 39.43% of share capital (as reported same-day by Zhitong Caijing and National Business Daily), with no profit warnings, regulatory or short-seller reports, or other negatives. The unlock is the share supply event fully discussed in C3 of this report; the valuation basis is not adjusted for the intraday price. Should the closing price fall significantly below HKD 18 (the bear-case floor), reassessment under the bear-case framework would be required.
Business model in brief: Branded tea chain retailer, with revenue split three ways: "franchisee wholesale (revenue recognized at delivery of goods) + direct-operated retail + online direct sales," at 63.2% offline / 36.5% online in 1H2026; of 3,845 stores, 94% are franchised—an asset-light model (intangible assets are only 0.9% of total assets, no goodwill, no bank borrowings). Upstream production is dual-track—in-house manufacturing (smart factories in Anxi/Wuyishan) plus OEM—with in-house production at 60.8% and rising; on the product side, focus is on star SKUs such as Zhengcong Tieguanyin (Race Pearl Tieguanyin), Niu Yi rock tea, and Dinghong black tea. There is no subscription or recurring revenue; revenue is essentially consumer goods wholesale + retail, with moderate-to-weak pricing power—the rise in gross margin from 52.3% to 55.6% was driven by higher in-house production share and mix upgrade, not direct price increases.
Cash conversion of earnings: OCF/net profit for FY2023–FY2025 and 1H2026 was 2.26/1.20/1.42/1.58 respectively (approximately 1.25 in 1H2026 after excluding one-off collections), and FCF/net profit was 1.23/0.75/1.13/1.38—over multiple years, cash conversion of book profits has been excellent overall, with no red flags of receivables build-up; fluctuations mainly stem from the timing of accounts payable for procurement and stocking (the company's explanation is internally consistent). On recurring earnings: FY2025 adjusted net profit of RMB 241 million vs. RMB 222 million attributable to shareholders, the difference being the add-back of listing expenses (conservative treatment, no SBC issue); government grants of RMB 8.74 million and impairments of RMB 2.40 million are both below 15% of attributable profit—no one-off gains masking underlying performance. The real point to note is the "availability" of net cash: of the RMB 1,219 million in cash-like assets, RMB 10.54 million is restricted deposits (RMB 4.06 million court-frozen + RMB 6.48 million prepaid card reserve), and the business needs retained cash to support working capital of RMB 588 million in inventory and RMB 471 million in payables; additionally, HK$388.4 million of IPO proceeds have designated-use restrictions—"net cash ≈ fully distributable" is a loose assumption.
Return on capital: FY2025 ROIC estimated at approximately 12.2% (NOPAT = operating profit of RMB 309 million × (1−26.1%) ÷ invested capital of approximately RMB 1.87 billion), broadly in line with the 13%–16% cost of equity range—the company's returns are roughly equal to its cost of capital, showing no moat-level profitability that substantially exceeds the cost of capital; TTM ROE of 15.8% relies mainly on the equity base before net cash deflates the denominator and on the inflection-point profits of 1H2026.
CapEx quality: CapEx fell continuously from RMB 213 million (FY2023) to RMB 65 million (FY2025), with CapEx/depreciation at 1.48→0.75→0.51, and 0.63 in 1H2026; 99.6% of IPO proceeds remain unused (only HK$1.5 million utilized as of 2026-06-30; the company attributes this to delayed foreign exchange registration, completed in 2026-01); "multiple smart factories in Anxi/Wuyishan/Yunnan over the next 3–5 years" has no disclosed construction start, and the RMB 14.78 million prepaid for Wuyishan land-use rights in 1H2026 is the only leading action. Growth vs. maintenance CapEx cannot be separated from disclosures (maintenance CapEx conservatively taken at the actual FY2025 figure of RMB 65 million).
Quality red flags: ① Near-full idling of IPO proceeds coexisting with "buybacks + large dividends"—contradictory capital allocation signals; ② Per-store revenue/store productivity model never disclosed—store expansion economics are unverifiable; ③ 1H2026 high growth relies on franchisee payments; channel inventory is a black box (the prospectus itself acknowledges third-party "inventory overhang" risk).
Say-do consistency: partially delivered, on the weak side. Three comparisons: ① The prospectus committed net proceeds of HK$389.9 million to be deployed across five major directions (commitment period through end-2025)—as of 2026-06-30 only 0.4% utilized, severely lagging (the company explains this as delayed foreign exchange registration, completed in 2026-01; the explanation is plausible but no deployment followed); ② FY2025 annual report outlook of "building multiple smart factories over the next 3–5 years"—CapEx declined for three consecutive years, no construction announcements, not begun; ③ FY2025 zero dividends citing "capital expenditure needs and market capitalization management," then in 2026 a pivot to a 51.5% payout interim dividend + consecutive buybacks—rapid policy shift, direction favorable to shareholders but consistency questionable (see C4's floor-supporting skepticism).
Shareholder friendliness: neutral and improving, pending verification. Pre-IPO payout ratios were 15.5%/16.1% in FY2023/2024; FY2025 zero dividends; 2026 interim dividend of RMB 102 million (51.5%) + buyback of HK$40.87 million (as of 9-30, approximately HK$229 million remaining under the HK$250 million mandate); no refinancing dilution (IPO issued only 9 million shares, 10.6% of total share capital), no equity incentive plans (annual report explicitly states "no equity incentive plans or employee stock ownership plans have ever been implemented"). If the final dividend lands in 2027-03, this could be upgraded to "shareholder friendly."
Risk signals: ① Highly concentrated family governance—the Wang Wenbin/Wang Wenli/Wang Wenchao brothers and relatives, acting in concert, hold approximately 50% of shares (approximately 55.9% of voting rights); 6 of 9 directors are family members; the agreement stipulates that deadlocks are decided by Chairman Wang Wenli; ② External shareholders IDG (6.14%), TF Capital (4.24%), and Nanhai Growth (3.71%) are financial investors, invested for approximately 8 years, with exit motivations post-lockup (no sell-down announcements as of 2026-10-28); ③ Related-party transactions consist of sales framework agreements with enterprises controlled by executives' relatives (Guangxi Jiuyun, Jiangxi Youyuan, etc.); period-end payables to related parties of only RMB 2.695 million—small in scale but requiring ongoing monitoring; ④ Sloppy disclosure details—two interim dividend announcements on the same day contained contradictory HKD conversion rates (HK$1.0379 vs. HK$1.3874 per share).
The company's statutory reporting is a single operating segment; the table below breaks down revenue by dimension (FY2025, revenue of RMB 2,196 million):
| Category/Channel | Revenue Share | YoY | One-line Business Logic |
|---|---|---|---|
| Tea products total | 88.9% | +2.8% | Core business; gross margin approximately 58.5% (1H2025 prospectus basis) |
| —Oolong tea (rock tea + Tieguanyin) | 31.2% | +7.1% (rock tea +12.6%) | Largest category, +52.3% overall in 1H2026, Fujian origin advantage |
| —Black tea | 20.3% | +7.2% | Driven by Dinghong SKU, +37.7% in 1H2026 |
| —Tea gift sets (gift boxes) | 9.3% | +16.2% | Holiday gifting scenarios; 2027 Spring Festival is a validation point |
| —Dark tea (Pu-erh) | 9.1% | -12.5% | Xinji Hao aged tea, price-cycle sensitive, rebounded +17.6% in 1H2026 |
| —White tea | 8.8% | -13.3% | Speculative hype receding, continued decline of 5.8% in 1H2026 |
| Non-tea products (tea ware + tea snacks) | 10.7% | Tea ware -12.2%/tea snacks +26.9% | Low-margin accessories (approximately 22%–23%), tea ware shrinking |
| Offline channels | 67.4% | +2.6% (1H2026 +29.7%) | Franchise wholesale model; large B2B customers as a new engine |
| Online channels | 32.2% | +2.0% (1H2026 +36.1%) | Gross margin above offline (approximately 56.9%–60.1%), instant retail growing fast |
Profit engine: Tea products, with 88.9% of revenue and approximately 58.5% gross margin, contribute an estimated ~95% of gross profit—non-tea categories (gross margin approximately 22%–23%, a gap of more than 35pp) are merely traffic-driving accessories; the money is made entirely in tea itself; within that, oolong tea (rock tea + high-end Tieguanyin SKUs) is the dual mainstay of profit and growth. The gross margin structure difference stems from different business natures: high-end loose-leaf tea prices on brand and origin perception, while tea ware and snacks are standardized commodities with no brand premium. Risk point: Pu-erh + white tea, together 17.9% of revenue, have declined year after year (Xinji Hao FY2025 -18.7%); if the aged tea market continues to weaken, the RMB 120 million in aged tea inventory tied to it (see financial engineering chapter) will come under pressure.
Disclosure cycle note: The company listed on 2025-10-28, with only one audited annual report (FY2025), supplemented by the prospectus accountant's report (FY2022–2024) and one interim report; cross-period consistency can only be assessed on a limited basis.
Accounting red flags: ① Aged tea inventory build-up with no impairment provision (moderate severity)—inventory aged over 36 months rose from RMB 80 million to RMB 120 million (+50%, 20.7% of total inventory); the company attributes this to "Pu-erh tea from 2022 and earlier still in the aging process to enhance value," and the annual report explicitly states "management has not identified any material matters relating to inventory provisions"—carried at cost and reliant on the Pu-erh aging appreciation assumption; a decline in tea prices would directly become impairment; ② Related-party distribution (low)—framework sales agreements signed with Guangxi Jiuyun and others controlled by executives' relatives; pricing and true end-market flows need monitoring; ③ Dividend announcement conversion contradiction (low)—two updated announcements on the same day showed HKD conversion rates of 1.0379 vs. 1.3874 per share; sloppy disclosure process.
Cross-period consistency: ① OCF/net profit swung widely at 2.26→1.20→1.42→1.58, consistent with the company's "payables and stocking timing" explanation (1H2026 also needs the one-off collections excluded); ② Revenue growth +16.8%→+1.0%→+2.5%→+31.8%, with the engine shifting from C-end to B-end (franchise purchasing + large customers), attribution consistent across periods; ③ Gross margin rose continuously at 52.3%→55.0%→55.6%, but FY2024 attributed it to "supply chain management and lower inventory costs" while FY2025 attributed it to "higher in-house production ratio"—inconsistent attribution across periods (fortunately, 1H2026 in-house production data supports the latter); ④ Inventory growth persistently outpacing revenue (+31.9% vs. +2.5%); the Spring Festival stocking + aging explanation is partially consistent with 1H2026 inventory growing only 0.8%, pending annual report verification.
Overall judgment: Based on the two periods of financials and the prospectus extracted here, no profit-manipulation-level financial engineering traces were found; the single item most worth monitoring is the aging and provisions of aged tea inventory.
Current market data (closing price HK$22.80 on 2026-10-27): Total market cap HK$1,938 million (approximately RMB 1,647 million); PE(TTM) 5.5x / PE(FY2025) 7.4x / PE(FY2026E, this report's forecast of RMB 330 million) approximately 5.0x; PB 0.87x (TTM ROE 15.8%); EV approximately RMB 602 million ≈ 2.0x TTM attributable profit / 2.4x FY2025 FCF; declared interim dividend implies a dividend yield of approximately 6.2%. Historical percentile: listed only ~12 months, PE/PB in the lowest range since listing (approximately 1%–2% percentile); sample too short—percentiles are for reference only. Liquidity: 30-day average daily turnover approximately HK$2.19 million (0.11% of market cap), last 10 days only approximately HK$0.93 million (0.05%, half below the 0.1%-of-market-cap threshold; single-day turnover on 2026-10-27 only HK$171 thousand)—institutional-scale capital cannot enter or exit; this is the largest structural reason for the valuation discount.
Market-implied expectations: Excluding net cash, the EV the market pays for the operating business is only approximately RMB 600 million; back-solving with a 13%–16% cost of equity, the current price implies perpetuity growth of normalized earnings of approximately -4% to +4% (midpoint approximately -1%). One-line summary: the current price requires that this company's earnings stagnate forever and its cash on hand is never distributed, while reality is that 1H2026 has already delivered +65% profit growth and a 51.5% payout ratio. The core of the disagreement is not "whether earnings are real" but "cash delivery" and "lockup supply"—the latter is real (C3), the former is verifiable (2027-03 final dividend).
Three-tier value (EPV, equity basis): Asset value (floor) approximately HK$18.54/share = net cash per share HK$14.47 + inventory at 50% liquidation approximately HK$4.07 (conservative basis, excluding fixed assets and receivables, and not deducting operating liabilities); zero-growth EPV approximately HK$24.7/share (range 21.6–26.6, cost of equity 13%–16%; normalized FCFE per share RMB 2.94 = HK$3.46, based on FY2025 FCF of RMB 250 million and 1H2026 FCF of RMB 273 million; bridge: normalized attributable profit RMB 280–300 million + D&A RMB 127 million − maintenance CapEx RMB 65 million − working capital absorption approximately RMB 40 million, with an approximately 85% cash conversion discount). The current price of HK$22.80 sits between the "asset floor of 18.54" and the "zero-growth EPV of 24.7," closer to the latter's lower bound: the growth option value is negative (the current price is at an approximately 8% discount to the zero-growth EPV midpoint—the market is not only paying nothing for growth but applying a discount). Smart factory expansion and online scaling are future scenarios and are not included in EPV. The three tiers are not additive: if the market believes net cash will be delivered through dividends (a 50% full-year payout ratio implies a yield of approximately 10%), the value center will move toward "EPV + cash delivery"; if not, EPV is the ceiling.
Three scenarios and odds (12 months, HK$/share):
| Scenario | Probability | Fair Range | vs. Current | Core Assumptions and Swing Factor |
|---|---|---|---|---|
| Bear | 0.30 | 18–21.5 | -21.1%~-5.7% | 2H revenue turns negative (channel stuffing receding + weak gifting, FY2026 attributable profit approximately RMB 260 million) + PE shareholder discounted sell-down + aged tea impairment; priced cross-checked by 5–6x PE and 9%–10% dividend yield methods |
| Base | 0.50 | 30–37 | +31.6%~+62.3% | 2H growth decelerates to +10%~+20% without stalling, full-year attributable profit RMB 320–340 million; final dividend lands making full-year payout ratio approximately 50% (DPS approximately HK$2.29, yield approximately 10%); exit multiple 7–8.5x FY2026E—anchored to HK-listed small-cap high-dividend stock pricing convention of 6.5%–8% dividend yield (implying HK$28.6–35.2) and the lower end of 10–12x PE for HK Stock Connect food & beverage small caps; the anchor is independent of the company's current price |
| Bull | 0.20 | 47–60 | +106%~+163% | Online/instant retail sustains 30%+ without slowing in 2H (attributable profit RMB 340–360 million) + buyback amplification + liquidity discount narrowing (10–12x); essentially the "cash discount disappearing" rather than growth delivery |
External coordinates: The only named sell-side firm, Huaxi Securities, maintains "Buy" (FY2026–2028 revenue of RMB 2,586/2,951/3,309 million, no target price); its implied 2H2026 revenue growth is only +4.5%, closer to our bear-to-base path, constituting a relatively conservative external anchor; among retail investors on Xueqiu etc., the "cigar-butt cash cow" narrative circulates (price HK$24.8 at time of writing). Own earnings forecast (results reconciliation anchor): FY2026E revenue RMB 2,650–2,760 million (implying 2H +10.3%~+20.0%), attributable profit RMB 320–340 million; FY2027E revenue RMB 2,950–3,150 million, attributable profit RMB 370–410 million—all above Huaxi's revenue forecasts (which imply 2H of only +4.5%; we judge they have not reflected 1H momentum). Method note: 2H growth halved from 1H and further discounted; the inability to strip out end-market sell-through share from franchisee payments is the biggest uncertainty.
Conclusion: Undervalued—above-average quality (high-end #1 brand, healthy cash conversion) coexists with a significantly cheap price, but the discount has causes (governance + liquidity + lockup); target price HK$30–37 = base case fair value, safety margin +31.6% (based on base-case fair value floor of HK$30). The basis for anchoring the base-case exit multiple (7–8.5x): HK small-cap high-dividend dividend-yield pricing convention and the lower end of peer/sector multiples, not the company's current 5.5x (the current multiple is for reference only).
Industry Definition and Market Size: China's loose-leaf tea market (traditional whole-leaf tea, excluding freshly-made tea beverages) reached approximately RMB 325.8 billion by sales revenue in 2024 (Frost & Sullivan, cited in Bama's prospectus), with a 2020–2024 CAGR of about 3%; it is expected to reach approximately RMB 356.4 billion in 2026 and RMB 407.9 billion by 2029, with a 2024–2029 CAGR of about 4.6%—a mature, low-growth industry. The structural highlight lies in price-tier stratification: the premium segment (>RMB 700/kg) was approximately RMB 103.1 billion in 2024, accounting for 31.6% of the total, with a 2019–2023 CAGR of 6.2% and an expected 2024–2029 CAGR of 5.6% to approximately RMB 135.3 billion—growing faster than the overall market. The industry's premiumization-driven structural upgrade is the beta for Bama's track. There is no official breakdown between branded tea and bulk tea, but evidence suggests bulk dominates: over 1.6 million tea-related enterprises and an overall CR5 of only about 2.4%.
Industry Chain and Value Distribution: Upstream tea farmers/cooperatives/primary processing plants—per the China Tea Circulation Association, in 2025 China had 53.1226 million mu of tea gardens, dry gross tea output of 3.6403 million tonnes, and a total output value of RMB 333.194 billion, implying an average gross tea price of about RMB 91.5/kg; output has grown year after year, with supply ample and even oversupplied. The midstream refining/blending stages add limited value; in the downstream branded retail stage—premium retail prices exceed RMB 700/kg, with roughly 8–10x value-add from gross tea to retail captured by brands and channels. Bama operates an integrated "midstream refining + downstream branded retail" model (60.8% self-production ratio), with strong bargaining power over upstream (oversupply + extreme fragmentation) and strong bargaining power over downstream franchisees (supply and pricing controlled by the brand, with revenue recognized upon shipment, partially transferring sell-through risk to franchisees), and neutral-to-strong pricing power with end consumers (high brand premium, but gift demand is heavily influenced by macro and business-activity fluctuations).
Supply-Demand and Competitive Landscape: Demand-side volume/price decomposition—volume (gifting + self-consumption) growing at low single digits, with price (premiumization) as the main driver; supply-side upstream is loose, midstream has 1.6 million small players, and after a wave of store closures in 2024–2025, channels are seeing divergent recovery in 2026. Concentration: overall CR5 about 2.4% (2024, combined revenue of the top five at RMB 8.202 billion), premium segment CR5 about 5.6% (5.5% in 2020, virtually unchanged in five years)—the narrative of "market share concentrating among leaders" is more a revenue-ranking story; structural evidence is weak. Entry barriers: brand mindshare (non-standardized agricultural products lack unified quality standards, requiring decades of accumulation) > channel network (Bama's 3,845 stores) > supply chain and intangible cultural heritage craftsmanship; price wars are not prominent (premium tea prices are rigid), and competitive weapons are advertising (Bama's 1H2026 ad spend of RMB 193 million, +40%) and franchise territory expansion. Substitutes: freshly-made tea beverages at approximately RMB 374.9 billion in 2025 (3.6x the premium loose-leaf tea market), with growth already slowing to 5.7% (expected to peak in 2028); ready-to-drink tea at about RMB 154.5 billion; coffee diversion—with substitutes themselves decelerating, marginal substitution pressure is easing, but competition for younger consumers remains fierce. Demand inflection point verdict: not confirmed—"younger consumers shifting to loose-leaf tea/health-conscious consumption" lacks quantifiable penetration data; counter-evidence is Lancang Ancient Tea's youth-oriented "Cha Mama + Yanleng" series down 21% in 1H2026 while the traditional gifting 1966 series rose 52.8%—incremental demand still comes from gifting/middle-aged-and-older consumers; Bama's strong 1H2026 growth was driven by channel expansion and marketing spend, not a demographic shift.
Cyclicality and Regulation: The industry is in a mature phase; in 2024–2025 upstream tea prices receded (weak Pu'er market, high channel inventories—Lancang Ancient Tea's inventory of RMB 895 million is about 5.5x its half-year revenue), and premium gifting remained weak; 2026 shows divergent recovery (Bama +31.8%, Lancang +36.8% off a low base, Tenfu -7.2%), reflecting a redistribution within the existing stock rather than an overall demand upturn. Leading indicators: net change in branded specialty stores, franchisee purchase volumes, advertising intensity, gross tea purchase prices and the Pu'er market, and leader inventories. Regulation is compliance-cost-type: food safety and pesticide residue national standards (GB 2763 series) applied routinely; the GB 23350-2021 excessive-packaging rules (from March 2025, tea packaging must not exceed three layers, packaging cost ratio ≤15% for products priced above RMB 200) compress the premium of "sky-priced gift boxes"; enforcement against gift-giving at festival occasions continues (the CCDI publication in September 2026 scrutinizing Mid-Autumn Festival and other occasions), constituting policy pressure on official/business demand for premium tea gifts—this is the industry's most important demand-side policy variable.
Peer Benchmarking (1H2026 / latest available):
| Company | Market Cap (HKD bn) | Revenue (RMB bn) | Revenue Growth | Gross Margin | ROE | PE/PB | Key Differentiation |
|---|---|---|---|---|---|---|---|
| Bama Tea | 1.938 | 1.402 (1H26) | +31.8% | 54.6% | TTM 15.8% | 5.5 / 0.87 | Premium full-category + nationwide franchise network, No.1 in scale/growth/ROE |
| Tenfu Tea (06868) | ~2.83 | 0.625 (1H26) | -7.2% | 51.3% | ~6% | 23.4 / 1.36 | Heavy-asset self-operated + shrinking distribution, 1,289 stores and net declining |
| Lancang Ancient Tea (06911) | ~0.356 | 0.163 (1H26) | +36.8% | 60.3% | FY2025 loss | Loss-making / — | Pu'er single-category, extremely heavy inventory, deep post-IPO share price decline |
| China Tea / Hexiaoyuan / Xiaoguan Tea | Unlisted | China Tea 2019: 1.628 | N/A | N/A | N/A | — | SOE full-category / Fujian-based direct rival / premium marketing benchmark |
Company Industry Positioning: Leader—No.1 nationwide in premium tea sales revenue for 2024 (per the commissioned Frost & Sullivan report, market share of about 1.7%, up from 1.1% in 2020; No.1 in Tieguanyin sales revenue for over 10 consecutive years, rock tea for 5 years, black tea for 4 years), and the largest tea company by revenue among HK-listed peers (about 1.65x Tenfu and 9.7x Lancang Ancient Tea). Moat = brand scarcity from 13 generations of tea-making heritage + franchise network and franchise recruitment capability across 3,845 stores + premium gifting mindshare and full-category coverage. Weaknesses = wholesale model with sales to franchisees at about 50% of revenue (sell-through invisible), growth highly dependent on advertising spend, declining average annual member purchase value (RMB 2,860 → 2,470) and per-store revenue. Caveat on methodology: the market share figure comes from Frost & Sullivan's commissioned paid report, and 1.7% × RMB 103.1 billion ≈ RMB 1.75 billion is roughly 80% of the company's 2024 revenue—the "premium" scope and the company's reported revenue are not the same dataset; the two figures are presented side by side for reference only.
Store Network: 3,504 stores at end-FY2024 (249 self-operated) → 3,773 at end-FY2025 (235 self-operated, net +269) → 3,845 at end-1H2026 (226 self-operated / 3,619 franchised, net +72 in half a year). Self-operated stores have been steadily closed from a historical peak of 316 down to 226—the company has explicitly stated a "low-efficiency store closure strategy," with self-operated stores shifting function from sales to brand showcase and new product testing; expansion relies entirely on franchising. The number of franchisee entities fell from 1,250 (end-2025) to 1,213 (end-1H2026)—stores increased while entities decreased, meaning the average store count per franchisee rose (existing franchisees opening multiple stores); this signal of tightening franchise recruitment warrants monitoring.
Unit Economics (Limited Visibility): The company never discloses per-store revenue, per-store profit, or same-store growth—this is the biggest blind spot in this analysis. Available proxy metrics: per-store revenue per prospectus/media reports fell from about RMB 448,000 in 2022 to about RMB 392,500 in 2024 (declining consecutively); 1H2026 revenue +31.8% vs. stores +7.3% implies a clear rebound in per-store wholesale volume, but this is "wholesale to franchisees" rather than end retail. Member data: over 26 million members and over 41 million online followers; average annual member purchase value declining from RMB 2,860 (2022) → RMB 2,470 (2024)—existing customer spending per member is falling, in tension with the premiumization narrative.
Channel Structure: Online share rose from 32.2% in FY2025 → 36.5% in 1H2026; online gross margin (~57%–60%) is higher than offline (~54%); instant retail (Taobao Shangou/Meituan Waimai instore delivery/JD Xiaosong) GMV +90% in FY2025 and +156% in 1H2026; the 3,845-store grid serves as instant retail fulfillment assets—the "store network" is shifting from a cost item to omni-channel infrastructure, an option easily overlooked in valuation. B2B corporate customization was the second engine of offline growth in 1H2026, but is not separately disclosed and customer composition is not visible.
Store Expansion Ceiling: With premium-segment CR5 at only 5.6% and the industry's top 50 brands collectively closing stores, the physical ceiling remains far off; the real constraint is franchisee profitability—if end-market sell-through persistently lags purchases, the franchise system will signal it before the financial statements do (franchisee entity count, stores per franchisee, returns and deposit changes are leading indicators).
Stance: Cautiously Bullish (confidence 0.58, 12 months). This is a classic small-cap deep value case: the price (5.5x PE, 0.87x PB, net cash at 63.5% of market cap, EV at 2x earnings) has already priced in the bearish scenario quite fully, with positive odds (base case +31.6% to +62.3%; bear case -5.7% to -21.1%); however, the path to realization is narrow—relying on three legs working simultaneously: normalization of final dividends, increased buyback volume, and absorption of unlock overhang—plus extremely poor liquidity (10-day average daily turnover of only about HKD 930,000, less than half the 0.1% market cap threshold). Any position decision must first resolve "can it be traded" before discussing "is it worth buying"; only suitable for small positions built in tranches with a holding period of 12 months or longer.
Strategy: Use the FY2026 annual report due March 2027 (revenue ≥RMB 2.65 billion, net profit attributable ≥RMB 320 million, final dividend ≥RMB 0.4/share) as the core verification point; during the 20 trading days after the share unlock (through late November 2026), watch HKEx disclosure of interests and buyback magnitude—absence of discounted sell-down signals plus amplified buybacks raises confidence, while a discounted placement reverts to the bear case framework.
Key Risks: ① 2H2026 revenue stall (inventory stocking unwinding)—growth narrative collapses, valuation re-rates to pure dividend framework (bear case HKD 18–21.5); ② aged tea inventory impairment (RMB 120 million aged >36 months not yet provisioned); ③ discounted sell-down/placement by controlling shareholder or PE shareholders; ④ liquidity trap persisting, with the discount failing to converge through market mechanisms; ⑤ policy suppression of premium gifting demand (festival gift-giving enforcement) and consumption downgrade; ⑥ capital allocation risk under family governance (idle IPO proceeds, related-party transactions, potential benefit transfers).
Monitoring Calendar: Dividend payment of interim dividend settled by 2026-11-04; Double 11 Tmall oolong tea category ranking (twelfth consecutive win verification) in November 2026 and disclosure of interests within 20 days post-unlock; franchisee Chinese New Year purchase intensity and contract liabilities quarter-over-quarter in January 2027; FY2026 annual report in late March 2027 (revenue/net profit/final dividend/channel breakdown/inventory aging as a four-in-one verification point); second unlock wave of 37.57% full-circulation conversion shares on 2027-07-08; IPO proceeds commitment exhaustion deadline on 2027-12-31.
Data and citation sources: Bama Tea FY2025 annual results announcement (2026-03-27), FY2025 annual report (2026-03-30), 1H2026 interim results announcement (2026-08-18), 2026 interim report (2026-09-10), prospectus (2025-10-20), monthly return of movements in securities (2026-10-05); Zhitong Finance/National Business Daily unlock coverage (2026-10-28); Huaxi Securities interim results commentary (2026-10-18); Frost & Sullivan (cited in prospectus); China Tea Circulation Association "2025 China Tea Production and Sales Situation Analysis Report"; CIC Consulting (as cited by Jiemian News). This report does not constitute investment advice.